188 related articles for article (PubMed ID: 33626541)
1. Genetic Polymorphisms in Activating Transcription Factor 3 Binding Site and the Prognosis of Early-Stage Non-Small Cell Lung Cancer.
Kang HG; Park JE; Lee SY; Choi JE; Do SK; Hong MJ; Lee JH; Jeong JY; Do YW; Lee EB; Shin KM; Lee WK; Choi SH; Lee YH; Seo HW; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Park JY
Oncology; 2021; 99(5):336-344. PubMed ID: 33626541
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in Epithelial-Mesenchymal Transition-Related Genes and the Prognosis of Surgically Treated Non-small Cell Lung Cancer.
Seok Y; Kang HG; Lee SY; Jeong JY; Choi JE; Jung DK; Jin CC; Hong MJ; Do SK; Lee WK; Park JY; Shin KM; Yoo SS; Lee J; Cho S; Cha SI; Kim CH; Jheon S; Lee EB; Park JY
Ann Surg Oncol; 2017 Oct; 24(11):3386-3395. PubMed ID: 28766235
[TBL] [Abstract][Full Text] [Related]
3. Genetic Variant of Notch Regulator DTX1 Predicts Survival After Lung Cancer Surgery.
Lee JH; Shin KM; Lee SY; Hong MJ; Choi JE; Kang HG; Do SK; Lee WK; Lee EB; Seok Y; Jeong JY; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Kim YC; Oh IJ; Na KJ; Kim MS; Lee JM; Yang HC; Jung CY; Park CK; Lee MK; Kim DK; Park JY
Ann Surg Oncol; 2019 Oct; 26(11):3756-3764. PubMed ID: 31313037
[TBL] [Abstract][Full Text] [Related]
4. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.
Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY
J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291
[TBL] [Abstract][Full Text] [Related]
5. TSC2 genetic variant and prognosis in non-small cell lung cancer after curative surgery.
Lee YH; Do SK; Lee SY; Kang HG; Choi JE; Hong MJ; Lee JH; Lee EB; Jeong JY; Shin KM; Lee WK; Seok Y; Cho S; Yoo SS; Lee J; Cha SI; Kim CH; Jheon S; Park JY
Thorac Cancer; 2019 Feb; 10(2):335-340. PubMed ID: 30585697
[TBL] [Abstract][Full Text] [Related]
6. A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma.
Campayo M; Navarro A; Viñolas N; Tejero R; Muñoz C; Diaz T; Marrades R; Cabanas ML; Gimferrer JM; Gascon P; Ramirez J; Monzo M
PLoS One; 2011; 6(7):e22509. PubMed ID: 21799879
[TBL] [Abstract][Full Text] [Related]
7. Glucose Transporter 1 Gene Variants Predict the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer.
Do SK; Jeong JY; Lee SY; Choi JE; Hong MJ; Kang HG; Lee WK; Seok Y; Lee EB; Shin KM; Yoo SS; Lee J; Cha SI; Kim CH; Neugent ML; Goodwin J; Kim JW; Park JY
Ann Surg Oncol; 2018 Oct; 25(11):3396-3403. PubMed ID: 30062472
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants in histone modification regions are associated with the prognosis of lung adenocarcinoma.
Kang HG; Lee YH; Lee SY; Choi JE; Do SK; Hong MJ; Lee JH; Jeong JY; Do YW; Lee EB; Shin KM; Lee WK; Choi SH; Seo HW; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Park JY
Sci Rep; 2021 Nov; 11(1):21520. PubMed ID: 34728688
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in glycolytic pathway are associated with the prognosis of patients with early stage non-small cell lung cancer.
Lee SY; Jin CC; Choi JE; Hong MJ; Jung DK; Do SK; Baek SA; Kang HJ; Kang HG; Choi SH; Lee WK; Seok Y; Lee EB; Jeong JY; Shin KM; Cho S; Yoo SS; Lee J; Cha SI; Kim CH; Lee YM; Lee IK; Jheon S; Park JY
Sci Rep; 2016 Oct; 6():35603. PubMed ID: 27767175
[TBL] [Abstract][Full Text] [Related]
10. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
Zheng J; Xu T; Chen F; Zhang Y
Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic characteristics and EGFR mutations in lung cancer patients aged below 45 years.
Xia J; Li H; Ji Y; Mi C; Chen G; Li P; Zhang R; Chen W; Wang J
Curr Probl Cancer; 2019 Aug; 43(4):363-370. PubMed ID: 30522775
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
[TBL] [Abstract][Full Text] [Related]
13. KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer.
Sullivan I; Salazar J; Arqueros C; Andrés M; Sebio A; Majem M; Szafranska J; Martínez E; Páez D; López-Pousa A; Baiget M; Barnadas A
Clin Transl Oncol; 2017 Jul; 19(7):884-890. PubMed ID: 28150169
[TBL] [Abstract][Full Text] [Related]
14. A functional polymorphism on chromosome 15q25 associated with survival of early stage non-small-cell lung cancer.
Jin G; Bae EY; Yang E; Lee EB; Lee WK; Choi JE; Jeon HS; Yoo SS; Lee SY; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Park JY
J Thorac Oncol; 2012 May; 7(5):808-14. PubMed ID: 22722785
[TBL] [Abstract][Full Text] [Related]
15. The Different Effect of VEGF Polymorphisms on the Prognosis of Non-Small Cell Lung Cancer according to Tumor Histology.
Lee S; Kang HG; Choi JE; Lee JH; Kang HJ; Baek SA; Lee E; Seok Y; Lee WK; Lee SY; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Park JY
J Korean Med Sci; 2016 Nov; 31(11):1735-1741. PubMed ID: 27709850
[TBL] [Abstract][Full Text] [Related]
16. Association of EGFR 1 Gene Alteration and their Association with Lung Adenocarcinoma Patients.
Ali Beg MM; Fahdil SR; Yadav P; Shukla KK; Mohan A; Saxena A
Asian Pac J Cancer Prev; 2019 Mar; 20(3):825-830. PubMed ID: 30912007
[TBL] [Abstract][Full Text] [Related]
17. Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis.
Maeda A; Nakata M; Yasuda K; Yukawa T; Saisho S; Okita R; Hirami Y; Shimizu K
Oncol Rep; 2013 Jan; 29(1):39-44. PubMed ID: 23064377
[TBL] [Abstract][Full Text] [Related]
18. Genetic Variants in One-Carbon Metabolism Pathway Predict Survival Outcomes of Early-Stage Non-Small Cell Lung Cancer.
Do SK; Choi SH; Lee SY; Choi JE; Kang HG; Hong MJ; Kim JH; Baek SA; Lee JH; Lee WK; Do YW; Lee EB; Shin KM; Jeong JY; Lee YH; Seo H; Yoo SS; Lee J; Cha SI; Kim CH; Seok Y; Cho S; Jheon S; Park JY
Oncology; 2020; 98(12):897-904. PubMed ID: 32791502
[TBL] [Abstract][Full Text] [Related]
19. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
Yeo MK; Choi SY; Seong IO; Suh KS; Kim JM; Kim KH
Hum Pathol; 2017 Oct; 68():103-111. PubMed ID: 28851662
[TBL] [Abstract][Full Text] [Related]
20. Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.
Micke P; Mattsson JS; Edlund K; Lohr M; Jirström K; Berglund A; Botling J; Rahnenfuehrer J; Marincevic M; Pontén F; Ekman S; Hengstler J; Wöll S; Sahin U; Türeci O
Int J Cancer; 2014 Nov; 135(9):2206-14. PubMed ID: 24710653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
